Some specialists from Great Britain declared that they have discovered a drug with the probable to ‘vaccinate’ those with a family history of breast cancer. If the drug is administered frequently to persons who have a family history of the cancer, researchers say it could, in result, ‘vaccinate’ them against the illness.

A mutation in the BRCA gene  is identified to be the contributing issue in 2,000 of the 44,000 UK breast cancer cases, each year. This damaged gene may be inherited from both sides of a family. Women who have inherited this altered gene are 85 per cent more prone to expand the illness, which is eight times that of a usual woman.

At the present time, a large percentage of women who have inherited the ‘rogue’ gene, decide to experience a mastectomy, as a defensive measure. The modern drug, known as AGO14699, could successfully vaccinate those with a family history, and save thousands of women the trauma of having their breasts removed.
This innovative drug, which belongs to a class of anti-cancer medicines called PARP inhibitors, is planned to take advantage of the ‘Achilles’ heel’ in hereditary cancers. Basically it will block DNA repair in the BRCA genes and wipe out their chances of multiplying.

This drug could as well be free of the side property connected with other cancer treatments such as ache, nausea and hair loss. Experts mention that the drug could also be used against other forms of cancers, as well as those of the prostate and the pancreas, though supplementary study is necessary in that area.

Dr Ruth Plummer, senior lecturer in medical oncology at Newcastle University mentioned that the implications for women and their families are huge for the reason that if you have the gene, there is a 50 per cent risk you will pass it on to your children. You are carrying a time bomb.
The drug is currently under